$ATNF Woody explained that 180 Life Sciences would be going back to the MHRA and FDA armed with longitudinal research published by researchers at the University of Groningen which correlate nodule size with eventual finger contraction in Dupuytren’s disease, alongside “a couple of other publications.”
2
21
21 Likes